WAT
Waters Corporation
NYSE: WAT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$292.13
-2.86% today
Updated 2026-04-29
Market cap
$28.68B
P/E ratio
27.12
P/S ratio
9.06x
EPS (TTM)
$10.77
Dividend yield
—
52W range
$275 – $414
Volume
1.1M
Waters Corporation (WAT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
20.30%
Operating margin
33.80%
ROE
29.30%
ROA
11.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.28B | $222.20M | 58.12% | 23.05% | 17.36% |
| 2007 | $1.47B | $268.07M | 57.16% | 23.68% | 18.20% |
| 2008 | $1.58B | $322.48M | 58.02% | 24.74% | 20.47% |
| 2009 | $1.50B | $323.31M | 60.31% | 26.33% | 21.57% |
| 2010 | $1.64B | $381.76M | 60.25% | 27.38% | 23.23% |
| 2011 | $1.85B | $432.97M | 60.54% | 28.55% | 23.39% |
| 2012 | $1.84B | $461.44M | 59.99% | 27.74% | 25.03% |
| 2013 | $1.90B | $450.00M | 58.86% | 27.17% | 23.63% |
| 2014 | $1.99B | $431.62M | 58.53% | 26.03% | 21.70% |
| 2015 | $2.04B | $469.05M | 58.74% | 27.78% | 22.97% |
| 2016 | $2.17B | $521.50M | 58.87% | 28.84% | 24.06% |
| 2017 | $2.31B | $20.31M | 58.99% | 28.68% | 0.88% |
| 2018 | $2.42B | $593.79M | 58.98% | 30.57% | 24.54% |
| 2019 | $2.41B | $592.20M | 58.00% | 29.44% | 24.61% |
| 2020 | $2.37B | $521.57M | 57.44% | 27.29% | 22.05% |
| 2021 | $2.79B | $692.84M | 58.49% | 29.50% | 24.87% |
| 2022 | $2.97B | $707.75M | 58.00% | 29.39% | 23.81% |
| 2023 | $2.96B | $642.23M | 59.57% | 27.66% | 21.72% |
| 2024 | $2.96B | $637.83M | 59.43% | 27.93% | 21.56% |
| 2025 | $3.17B | $642.63M | 57.77% | 28.22% | 20.30% |